Genes within 20 kb of binding sites belonging to cluster C1 and whose expression was impacted by FOXM1 knockdown were used to generate a gene predictor that was employed to interrogate two large, independent data sets [38],[41] of ERα-positive breast cancer patients treated with TAM. This evidence concerns the gene FOXM1 and breast carcinoma.